EGFR and neoplasm: At the protein level, immunoblotting assays illustrated that YY1 was readily detectable in a wide spectrum of oncogene-driven lung cancer cell lines (Fig. 3C), as well as in most primary tumor samples regardless of EGFR mutation (Fig. 3D).